Skip to content

Cytokine Filter Usage During Open Thoracoabdominal Aortic Aneurysm Repair- a Single-center Randomized Prospective Trial

Cytokine Filter Usage During Open Thoracoabdominal Aortic Aneurysm Repair- a Single-center Randomized Prospective Trial- Cytosorb and Its Imapct on Open TAAA Repair Outcome

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04765748
Acronym
TAAA-Cytosorb
Enrollment
20
Registered
2021-02-21
Start date
2021-02-11
Completion date
2022-12-27
Last updated
2024-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Response, Postoperative Complications

Brief summary

Prospecrtive study including 20-30 randomized patients treated by open repair because of an TAAA larger than 55 mm During the surgery, a heart lung machine is applied for distal perfusion during aortic cross clamping to enable distal organ perfusion. Regardless an intensive inflammatory reaction is a well known effect after reperfusion, leading to a uncontrolled inflammation during th first days after surgery. This may be associated to bad outcome and decreased survival rates. By the application of a intraoperative cytokine and DAMP filter this negative ffect could be reduced, resulting in a better outcome after surgery.

Detailed description

Prospecrtive study including 20-30 randomized patients treated by open repair because of an TAAA larger than 55 mm During the surgery, a heart lung machine is applied for distal perfusion during aortic cross clamping to enable distal organ perfusion. Regardless an intensive inflammatory reaction is a well known effect after reperfusion, leading to a uncontrolled inflammation during th first days after surgery. This may be associated to bad outcome and decreased survival rates. By the application of a intraoperative cytokine and DAMP filter this negative ffect could be reduced, resulting in a better outcome after surgery.

Interventions

DEVICECytosorb

Cytokine filter, which can be used intraoperatively while using a heart lung machine

Sponsors

RWTH Aachen University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years

Inclusion criteria

Suffering from a TAAA larger than 55mm

Exclusion criteria

immunosupprive therapy pregnancy \-

Design outcomes

Primary

MeasureTime frameDescription
Amount of perioperative catecholamine usage in mg/dl for the first seven days after surgery7 days perioperatively -10 day postoperativelyamount measured in mg/dl
Amount of transfusion required during and after the surgery, assessed in transfusion more or less than 5 blood bags7 days perioperatively 5-10 day postoperativelypacked cells, erythrocyte concentrate

Secondary

MeasureTime frameDescription
Acute kidney injury, measured using serum creatinine in mg/dl7 days perioperatively, -10 day postoperativelyAKI assessed according to the KDIGO classification perioperatively for the first 7 days after surgery
Patients survival for the first 12 months after surgery12 months 10-14 months postopertaibelySurvival yes/no within the first 12 months after surgery

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026